The Internet Journal of Dermatology最新文献

{"title":"Palisaded Encapsulated Neuroma (PEN)","authors":"S. Repertinger, D. Sarma","doi":"10.5580/1619","DOIUrl":"https://doi.org/10.5580/1619","url":null,"abstract":"Palisaded encapsulated neuroma (PEN), while not an uncommon benign neural tumor of the dermis, is nevertheless often misdiagnosed clinically and histologically. A case of PEN of the skin is presented with a brief review of the literature. Distinguishing features from other benign neural tumors of the skin, in particular schwannoma and neurofibroma, are emphasized.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131494097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Soft-tissue augmentation devices: longevity of effects","authors":"U. Bauer","doi":"10.5580/2905","DOIUrl":"https://doi.org/10.5580/2905","url":null,"abstract":"The search for an ideal device or technique intended for soft-tissue augmentation has led to the development of a myriad of procedures and products. Currently, minimally invasive options can be sub-divided into those which offer temporary or permanent effects. The durability of results offered by these techniques and devices are presented here, focusing on products approved in the United States. Collagens and hyaluronic acid-based products offer effective results that are short term, generally providing a few months of augmentation. Fat replacement offers variable results and devices, such as polymethylmethacrylate, can give permanent correction. Long-lasting devices that are not permanent, such as calcium hydroxylapatite and poly-L-lactic acid, fill the gap between temporary and permanent devices, and can offer effective, durable correction.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128056369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Azithromycin Therapy for Multiple Eruptive Milia: A Report of a Case, New Treatment Option, and Review of the Literature","authors":"E. O'Shea, A. Mehta, A. Levy, Jamie L Frey, R. Skinner","doi":"10.5580/1f46","DOIUrl":"https://doi.org/10.5580/1f46","url":null,"abstract":"This is a case report, new treatment option, and review of the literature of multiple eruptive milia in patients with no genetic predisposition for forming milia. We report a case of a 71 year-old female with multiple eruptive milia in bilateral axillae which greatly improved after three months of azithromycin therapy. Multiple eruptive milia are a rare phenomenon of unknown etiology with only nine reported cases in the literature.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132543992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"International Society of Cutaneous Lymphoma (ISCL) and the European Organization of Research and Treatment of Cancer (EORTC) revisions to the staging and classification of mycosis fungoides and SÈzary syndrome.","authors":"M. Duvic, E. Olsen","doi":"10.5580/80e","DOIUrl":"https://doi.org/10.5580/80e","url":null,"abstract":"Madeleine Duvic, MD, is Professor of Internal Medicine and Dermatology, and Deputy Chairman of the Department of Dermatology at The University of Texas, M. D. Anderson Cancer Center in Houston, Texas. She is a founding member of the United States Cutaneous Lymphoma Consortium (USCLC), a Board member of the International Society for Cutaneous Lymphoma, and also serves as Director of The Cutaneous Lymphoma Clinic at MD Anderson Cancer Center. Dr. Duvic has also served on the Board of Directors of the American Academy of Dermatology (AAD). She is certified in Internal Medicine and Dermatology. She has been a principal and co-principal investigator on numerous clinical trials studying the immunology of T-cell mediated disorders and skin cancers, as well as clinical drug development and translational research in T-cell lymphomas, melanoma, and various skin cancers. A prolific author, she has written manuscripts, book chapters, abstracts, and over 300 peer-reviewed journal articles. She is co-author on a recent book on Retinoids and Carotenoids in Dermatology. Dr. Olsen is Professor of Dermatology and Oncology at Duke University Medical Center and the founder and Director of the Duke Cutaneous Lymphoma Research and Treatment Center. She is a Past President, SecretaryTreasurer and member of the Board of Directors of the International Society for Cutaneous Lymphomas (ISCL) and has chaired the ISCL initiatives on the revisions to 1) the staging and classification of Mycosis Fungoides (MF) and Sezary Syndrome (SS) (published in Blood 2007) and 2) standardized response criteria and endpoints for MF and SS (in progress). She is a founder and current President of the United States Consortium for Cutaneous Lymphomas (USCCL), a multidisciplinary group whose mission is to enhance patient care through a national registry of patients with cutaneous lymphoma and collaborative clinical trials. She has authored over 90 original articles and is the editor of two textbooks. Dr. Olsen is currently on the Board of Directors of the American Academy of Dermatology (AAD) and Deputy Chair of the AAD Patient Advocacy Task Force. As background to the following educational activity, this brief review will discuss the International Society of Cutaneous Lymphoma (ISCL) and the European Organization of Research and Treatment of Cancer (EORTC) revisions to the staging and classification of mycosis fungoides and Sezary syndrome.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114338745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sequential nasal eosinophil determinations in an allergy practice","authors":"R. Lin","doi":"10.5580/12e","DOIUrl":"https://doi.org/10.5580/12e","url":null,"abstract":"Nasal eosinophils are often observed in allergic rhinitis, nasal polyposis, allergic fungal sinusitis, and non-allergic rhinitis with eosinophilia syndrome(NARES). Determinations of nasal eosinophils quantities are performed by most clinical laboratories and are often viewed as an adjunct to diagnosing upper airway inflammatory disease(1). Although increasing nasal eosinophils have been observed during seasonal allergen exposure(2), the role of monitoring nasal eosinophils has not been defined in the context of clinical practice. The purpose of this paper is to describe serial nasal eosinophil quantities in 3 patients treated over time in a single allergy practice and to discuss the relevant recent literature regarding nasal eosinophil quantification techniques and their utility.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"125 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122509665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sister Mary Joseph Nodule: An Unusual Case Report with Review of Literature","authors":"I. Dar, M. Kamili, S. Dar, F. Kuchhai","doi":"10.5580/d28","DOIUrl":"https://doi.org/10.5580/d28","url":null,"abstract":"Sister Mary Joseph Nodule or Sister Mary Joseph Sign refers to a palpable nodule bulging into the umbilicus as a result of metastasis of a malignant cancer in the pelvis or abdomen. Gastrointestinal malignancies account for about half of the underlying sources (gastric, colonic, pancreatic cancer), gynaecologic (ovarian, uterine cancer), unknown primary tumours & rarely bladder or respiratory malignancies cause umbilical metastasis. The mechanism of spread of cancer to the umbilicus is unknown but proposed mechanisms include direct transperitoneal spread via lymphatics running along the obliterated umbilical vein, hematogenous spread or via remnant structures like the falciform ligament, median umbilical ligament or a remnant of the umbilical duct.The Sister Mary Joseph Nodule is associated with multiple peritoneal metastasis and signifies a poor prognosis. A rare case of a Sister Mary Joseph Nodule manifesting as ascites, cachexia and bleeding per rectum from an unknown primary adenocarcinoma is presented.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126420711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of combined systemic retinoids and phototherapy in the management of intermediate stage CTCL","authors":"Matthew C. Fox, T. Anderson","doi":"10.5580/99d","DOIUrl":"https://doi.org/10.5580/99d","url":null,"abstract":"Dr. Anderson is an Associate Professor and Director of Photo Medicine for the Department of Dermatology at the University of Michigan Medical Center in Ann Arbor, Michigan. He is also the Medical Director of the Dermatology Satellite office, located at our new facilities at Domino's Farms. He is also the Medical Director of the U-M Dermatology Treatment Center of Ann Arbor and formerly the Chief of the Dermatology Service at the Ann Arbor Veteran's Adminstration Hospital from 1986 to 1993. He is currently Co-Director of the Multidisciplinary Cutaneous Lymphoma Program. Dr Anderson is a member of the American Academy of Dermatology, American Dermatological Association, American Society For Photobiology, International Pigment Cell Society, International Society for Cutaneous Lymphoma, Photomedicine Society, Society For Investigative Dermatology, Medical Advisory Board for the Cutaneous Lymphoma Foundation, and past president of the Michigan Dermatological Society. In recognition of his expertise in the diagnosis and treatment of skin diseases, Dr. Anderson has been listed by Best Doctors in America® since 1994.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128494657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-Acting Beta agonists and their relation to increased Asthma Morbidity and Mortality. The FDA Meta-Analysis","authors":"G. Pesola, T. Lone, Ramani Gosala","doi":"10.5580/60b","DOIUrl":"https://doi.org/10.5580/60b","url":null,"abstract":"When long-acting beta-agonists (LABA) were initially introduced overseas, salmeterol was compared head to head with albuterol in a randomized, double blind study over 16 weeks (1) in addition to usual asthma care. There was a 3fold greater probability of death with the use of salmeterol (12/16,787) compared to albuterol (2/8,393). This outcome comparison did not reach statistical significance and the results did not address the issue of the use of inhaled steroids as background treatment with LABA. In the U.S. the FDA requested GlaxoSmithKline obtain more data related to its product salmeterol, sold as Serevent or Advair and this resulted in the SMART study.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133377495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unusual case of acne fulminans: face predominant without chest and trunk lesion","authors":"K. Yamanaka, D. Tsuruta, I. Kurokawa, M. Ishii, Hiromi Kobayashi","doi":"10.5580/f1b","DOIUrl":"https://doi.org/10.5580/f1b","url":null,"abstract":"Acne fulminans is a rare severest acne mainly affected with teenage boys with sudden onset of fulminant necrotizing acne presenting simultaneously with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome-like bone lesions and systemic symptoms. Histopathologically, massive inflammatory process around the sebaceous glands is observed. We present a case of face predominant acne fulminans without back and chest lesion. Thus far, there have been no definite reports of acne fulminans without back and chest lesion. Differential diagnosis between rosacea fulminans and acne fulminans were discussed.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126550108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Common papules with uncommon cause","authors":"J. Itämies, R. Nissi","doi":"10.5580/8f2","DOIUrl":"https://doi.org/10.5580/8f2","url":null,"abstract":"In Central Europe, bites from the common bed bug, (Cimex lectularius) are nowadays rather uncommon. However, the incidence of skin disease secondary to infestation with a human bedbug has increased in United States and United Kingdom.We describe a patient suffering from pruritus and erythematous papules. The etiology of his cutaneous lesions was discovered to be a bedbug infestation in the home, when the patient noted small brownish animals in his bed and decided to bring them to the local university to resolve the case.","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130496161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}